Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, has received US Food and Drug Administration (FDA) clearance for its Solus Gold Embolization Device, a next-generation product for peripheral vascular occlusion.
News | Embolization devices
Artio Medical Receives FDA Clearance for Solus Gold Embolization Device

March 29, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral ...

Home March 29, 2022
Home
Eko, a digital health company advancing heart and lung disease detection, has announced the launch of its newly-redesigned Eko App, which will transform patient interactions into an opportunity to screen for cardiovascular disease.
News | Heart Failure
Eko Launches Screening Solution to Help Catch Heart Disease Early
March 29, 2022 – Eko, a digital health company advancing heart and lung disease detection, has announced the launch of ...
Home March 29, 2022
Home
Impulse Dynamics, a company dedicated to innovative treatments for chronic heart failure, has successfully completed the requirements for certification of its quality management system (QMS) under the new Medical Device Regulation (MDR) (EU 2017/745 ) now in force in the European Union (EU).
News | Heart Failure
Impulse Dynamics' Quality Management System Receives Certification Under European Union Medical Device Regulation
March 29, 2022 – Impulse Dynamics, a company dedicated to innovative treatments for chronic heart failure, has ...
Home March 29, 2022
Home
Today the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) approved the use of a second COVID-19 booster shot for adults over age 50 and certain immunocompromised individuals, including heart transplant patients.
News | Coronavirus (COVID-19)
Second Booster Approved as Option for Additional Protection Against COVID-19

March 29, 2022 — Today the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention ...

Home March 29, 2022
Home
HeartPoint Global, a leading medical device company dedicated to providing high-quality, minimally invasive cardiac care globally, announced another major milestone in the ongoing pre-clinical trials of the HeartPoint Global Implant System (HPGS), a first-of-its-kind patented, adjustable system which focuses on treating devastating left heart diseases, congestive heart failure, and structural pulmonary hypertension.
News | Heart Failure
HeartPoint Global's Implant System Proves Safety and Efficacy

March 28, 2022 — HeartPoint Global, a leading medical device company dedicated to providing high-quality, minimally ...

Home March 28, 2022
Home
Aeson total artificial heart showing Open view with pumps and electronics (blue), blood chambers (maroon) and conduits (top, white). Image courtesy of Carmat.
News | Artificial Heart
Carmat Announces the Restart of Production

March 28, 2022 — Carmat, the designer and developer of the world’s most advanced total artificial heart, aiming to ...

Home March 28, 2022
Home
In the first study to examine differences by sex and race in outcomes following the seven most common procedures for heart problems, researchers found that women are less likely to undergo these procedures—and even when women do receive these procedures, they are more likely than men to die while in the hospital, according to data that will be presented at the American College of Cardiology’s 71st Annual Scientific Session.
News | Womens Cardiovascular Health
Women Less Likely to Receive Life-saving Heart Procedures
March 25, 2022 – In the first study to examine differences by sex and race in outcomes following the seven most common ...
Home March 25, 2022
Home
Consumers are increasingly using smartwatches and other wearable devices to measure their heart rate and rhythm during exercise and for overall health monitoring.
News | Wearables
How Accurate is Smartwatch Heart Data? It Depends on your Skin Tone
March 25, 2022 – Consumers are increasingly using smartwatches and other wearable devices to measure their heart rate ...
Home March 25, 2022
Home
People experiencing high levels of noise from cars, trains or planes were more likely to suffer a heart attack than people living in quieter areas, according to a study presented at the American College of Cardiology’s 71st Annual Scientific Session.
News | Heart Failure
Living Near Noise Pollution Tied to Greater Risk of Heart Attack
March 25, 2022 – Living in a noisy environment can be annoying, but it might also harm your health. People experiencing ...
Home March 25, 2022
Home
Extreme heat accounted for about 600-700 additional deaths from cardiovascular disease annually over a decade-long period in the U.S., according to a study presented at the American College of Cardiology’s 71st Annual Scientific Session.
News | Heart Failure
As Temperatures Spike, so do Deaths from Heart Disease
March 25, 2022 – Extreme heat accounted for about 600-700 additional deaths from cardiovascular disease annually over a ...
Home March 25, 2022
Home
A heart attack’s impact on the brain may be more serious than previously understood. About 1 in 3 heart attack survivors showed significant mental decline in the days and months following their heart attack, according to a study presented at the American College of Cardiology’s 71st Annual Scientific Session.
News | Heart Failure
Heart Attack Survivors May be at Greater Risk of Mental Decline
March 25, 2022 – A heart attack’s impact on the brain may be more serious than previously understood. About 1 in 3 heart ...
Home March 25, 2022
Home
Despite recent efforts to improve women’s leadership in cardiovascular clinical trial research over the last decade, the number of female principal investigators (PIs) still falls well below the number of males leading similar heart studies, according to a study presented at the American College of Cardiology’s 71st Annual Scientific Session.
News | Cardiovascular Clinical Studies
Study: Women Still Missing from Cardiovascular Clinical Trial Leadership

March 25, 2022 – Despite recent efforts to improve women’s leadership in cardiovascular clinical trial research over the ...

Home March 25, 2022
Home
A new clinical trial found daily consumption of cranberries for one month improved cardiovascular function in healthy men.
News | Heart Failure
Study: 100g of Cranberries a Day Improves Cardiovascular Health

March 25, 2022 – A new clinical trial found daily consumption of cranberries for one month improved cardiovascular ...

Home March 25, 2022
Home
Scientists at the Ural State Medical University, the Ural Federal University, and the University of Copenhagen have developed new criteria for diagnosing headaches arising from ischemic stroke. It will help to predict, prevent, promptly identify and treat this dangerous pathology in a timely manner.
News | Stroke
The Nature of the Headache can Predict Ischemic Stroke
March 25, 2022 – Scientists at the Ural State Medical University, the Ural Federal University, and the University of ...
Home March 25, 2022
Home
Genetic Catalytic Inactivation of GRK5 Impairs Cardiac Function in Mice Via Dysregulated P53 Levels
News | Heart Failure
Scientists Elucidate Molecular Pathway Driving Maladaptive Processes in Heart Failure

March 25, 2022 – Under stress, the human heart struggles to pump blood efficiently through the body. Over time, as the ...

Home March 25, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now